+499.5%
MRNA vs ALLY
+9.5%
+490.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ALLY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.3% | -2.6% | -2.3% |
| 7D | +5.5% | +3.7% | +1.8% | +4.4% |
| 30D | +158.7% | -2.3% | +161.0% | +161.4% |
| 3M | +182.1% | +3.8% | +178.3% | +177.4% |
| 6M | +151.8% | +9.7% | +142.1% | +142.9% |
| YTD | +393.6% | -1.4% | +395.0% | +391.3% |
| 1Y | +499.5% | +8.2% | +491.2% | +506.0% |
| All | +499.5% | +9.5% | +490.0% | +506.0% |
Cumulative growth
Daily Returns
Daily percentage return beside ALLY.
Daily Out/Under-Performance
Portfolio return minus ALLY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALLY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ALLY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling